List of Contents

Automated Liquid Handling Market Size, Share, and Trends 2024 to 2034

The global automated liquid handling market size accounted for USD 1.33 billion in 2024, grew to USD 1.44 billion in 2025 and is projected to surpass around USD 2.90 billion by 2034, representing a healthy CAGR of 8.12% between 2024 and 2034.

  • Last Updated : November 2024
  • Report Code : 2697
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Automated Liquid Handling Market 

5.1. COVID-19 Landscape: Automated Liquid Handling Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Automated Liquid Handling Market, By Modality

8.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Modality, 2024-2034

8.1.1. Fixed Tips

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Disposable Tips

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Automated Liquid Handling Market, By Procedure

9.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Procedure, 2024-2034

9.1.1. PCR Setup

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. High-Throughput Screening

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Serial Dilution

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Array Printing

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

9.1.5. Whole Genome Amplification

9.1.5.1. Market Revenue and Volume Forecast (2021-2034)

9.1.6. Cell Culture

9.1.6.1. Market Revenue and Volume Forecast (2021-2034)

9.1.7. Plate Reformatting

9.1.7.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Automated Liquid Handling Market, By Type 

10.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Type, 2024-2034

10.1.1. Benchtop Workstation

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Standalone

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Multi-Instrument System

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Automated Liquid Handling Market, By End User 

11.1. Automated Liquid Handling Market Revenue and Volume Forecast, by End User, 2024-2034

11.1.1. Biotechnology & Pharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Academic & Government Research Institutes

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Contract Research Organizations

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Automated Liquid Handling Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)

Chapter 13. Company Profiles

13.1. QIAGEN NV.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agilent

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Anton-Paar

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Analytik Jena

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Aurora Biomed

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Elemental Scientific

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Distek

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ellutia

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Fritsch International

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. EST Analytical

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us